BI-RADS Category 2: Benign Finding
A BI-RADS category 2 assessment indicates a definitively benign finding with essentially zero risk of malignancy, and the patient should return to routine screening intervals without any additional follow-up imaging or biopsy. 1
What BI-RADS 2 Means
BI-RADS category 2 represents findings that are clearly benign on imaging. These are lesions with characteristic benign features that radiologists can confidently identify as non-cancerous. The malignancy rate for BI-RADS 2 lesions is 0% based on validation studies 2, 3.
Common examples of BI-RADS 2 findings include:
- Simple cysts
- Intramammary lymph nodes
- Calcified fibroadenomas
- Fat-containing lesions (lipomas, oil cysts, galactoceles)
- Vascular calcifications
- Implants
- Architectural distortion from prior surgery with stable appearance
Recommended Management
The NCCN guidelines explicitly state that for BI-RADS category 2, the patient should resume routine screening. 1 This means:
- No short-term follow-up imaging is needed
- No biopsy is indicated
- Return to age-appropriate screening intervals (typically annual mammography for average-risk women ≥40 years)
Key Clinical Distinctions
It's critical to distinguish BI-RADS 2 from BI-RADS 3 (probably benign):
- BI-RADS 2: Definitively benign (0% malignancy risk) → routine screening
- BI-RADS 3: Probably benign (≤2% malignancy risk) → requires short-term follow-up at 6 months, then every 6-12 months for 1-2 years 1, 4
Common Pitfalls to Avoid
Do not order unnecessary biopsies or additional imaging for BI-RADS 2 lesions. Research confirms that breast biopsies are unnecessary in these cases, as the frequency of malignancy is zero 2. Overtreatment of benign findings leads to:
- Patient anxiety
- Unnecessary procedures and costs
- Potential complications from unneeded interventions
Ensure the BI-RADS category matches the clinical context. The same BI-RADS terminology applies to both screening (asymptomatic) and diagnostic (symptomatic) settings, which can create confusion 1. If a patient has a palpable mass but imaging shows only benign findings (BI-RADS 2), verify that the imaging finding corresponds geographically to the clinical concern. If there's discordance, the palpable finding requires separate workup.
Quality Assurance
The positive predictive value for BI-RADS 2 in clinical practice is 0%, meaning no cancers should be found in this category 3. This has been validated across multiple imaging modalities including mammography, ultrasound, and MRI 2. Routine auditing of BI-RADS categories is now recommended to ensure appropriate categorization 5.